AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation (Q24306227)

2

0 references

L Wei

3

0 references

X Wu

4

0 references

D Wu

5

0 references

S Lin

6

0 references

Z Wang

7

0 references

Z Ye

8

0 references

S-C Lin

Identification of a novel nuclear domain

9

0 references

language of work or name

English

0 references

publication date

10 March 2011

0 references

published in

Oncogene

0 references

volume

30

0 references

issue

10

0 references

page(s)

1194-204

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

PML is a direct p53 target that modulates p53 effector functions

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

The function of PML in p53-dependent apoptosis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Identification of three major sentrinization sites in PML

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Structure and Function in the Nucleus

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

PML interaction with p53 and its role in apoptosis and replicative senescence

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Daxx: death or survival protein?

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

The role of PML in tumor suppression

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

The mechanisms of PML-nuclear body formation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Role of PML in cell growth and the retinoic acid pathway

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

PML is essential for multiple apoptotic pathways

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.499

Regulation of apoptosis by PML and the PML-NBs.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

The PML gene is not involved in the regulation of MHC class I expression in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Characterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Loss of the tumor suppressor PML in human cancers of multiple histologic origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Detection of point mutations of the Axin1 gene in colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Axin determines cell fate by controlling the p53 activation threshold after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Changes of AXIN-1 and beta-catenin in neuroepithelial brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

PML induces a novel caspase-independent death process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

New insights into the role of PML in tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Axin and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Identification of a tumour suppressor network opposing nuclear Akt function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

PML3 Orchestrates the Nuclear Dynamics and Function of TIP60

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.499